Estimated Net Worth
- $6.8 M - $16.1 M
Salary
- Unknown
Employment
- Started 07/27/2023
Records
- OGE Form 278t (05/31/2023)
- OGE Form 278t (05/25/2023)
- OGE Form 278t (05/19/2023)
- OGE Form 278t (05/12/2023)
- OGE Form 278t (05/10/2023)
- OGE Form 278t (04/18/2023)
- OGE Form 278t (04/11/2023)
- OGE Form 278t (04/01/2023)
- OGE Form 278t (03/31/2023)
- OGE Form 278t (03/28/2023)
- OGE Form 278t (03/21/2023)
- OGE Form 278t (03/07/2023)
- OGE Form 278t (02/07/2023)
- OGE Form 278t (02/03/2023)
- OGE Form 278t (02/03/2023)
- OGE Form 278t (01/31/2023)
- OGE Form 278t (01/31/2023)
- OGE Form 278t (01/28/2023)
- OGE Form 278t (01/27/2023)
- OGE Form 278t (01/25/2023)
- OGE Form 278t (01/23/2023)
- OGE Form 278t (01/20/2023)
- OGE Form 278e (01/19/2023)
- OGE Form 278t (01/18/2023)
- OGE Form 278t (01/18/2023)
- OGE Form 278t (01/17/2023)
- OGE Form 278t (01/14/2023)
- OGE Form 278t (01/11/2023)
- OGE Form 278t (01/07/2023)
- OGE Form 278t (11/22/2022)
- OGE Form 278t (11/15/2022)
- OGE Form 278t (11/11/2022)
- OGE Form 278t (11/11/2022)
- OGE Form 278t (11/01/2022)
- OGE Form 278t (10/28/2022)
- OGE Form 278t (10/18/2022)
- OGE Form 278t (10/04/2022)
- OGE Form 278t (09/01/2022)
- OGE Form 278t (08/11/2022)
- OGE Form 278t (06/16/2022)
- OGE Form 278t (04/20/2022)
- OGE Form 278t (04/09/2022)
- OGE Form 278t (03/29/2022)
- OGE Form 278t (03/22/2022)
- OGE Form 278t (03/10/2022)
- OGE Form 278t (03/07/2022)
- OGE Form 278t (03/04/2022)
- OGE Form 278t (03/01/2022)
- OGE Form 278t (02/27/2022)
- OGE Form 278t (02/16/2022)
- OGE Form 278t (02/15/2022)
- OGE Form 278t (02/13/2022)
- OGE Form 278t (02/02/2022)
- OGE Form 278t (01/19/2022)
- OGE Form 278e (04/06/2021) [4]
[#]
Indicates number of lines involving "Nanocan Therapeutics Corporation".
Financial Disclosure Details - OGE Form 278e (04/06/2021)
Positions Held Outside United States Government
# | Organization | City | Position | To |
---|---|---|---|---|
12 | Princeton, New Jersey | Advisory Board member | Present |
Employment Agreements and Arrangements
# | Employer Or Party | City | Status And Terms | Date |
---|---|---|---|---|
8 | Princeton, New Jersey | I was granted options to purchase 21,375 shares at an exercise price of $.09 per share. Of those, 4750 have vested. Pursuant to company policy, the expiration date for the exercise of options is July, 2030. I will retain these options until that date, at which point, I would be required to decide whether or not to exercise them. | 7/2020 | |
9 | Princeton, New Jersey | I was granted options to purchase 21,375 shares at an exercise price of $.09 per share. Of those, 16,625 have not yet vested. Pursuant to company policy and the terms of the company’s equity incentive plan, the board has the discretion to accelerate vesting for advisory board members and employees who leave the company to enter public service. The board has determined to fully vest my options. I will retain my vested stock options and must decide prior to the option exercise date of July 30. 2030 whether or not I will exercise them. | 7/2020 |
Sources of Compensation Exceeding $5,000 in a Year
# | Source | City | Duties |
---|---|---|---|
12 | Princeton, New Jersey | Advisory board member |
Do you have information about Jack Markell that is missing from this database?
Drop us a line at [email protected].